Spanish healthcare VC market confirming new heights of financing volumes

For the second time in a row, the Spanish healthcare VC market reaches a financing threshold of >EUR 300, doubling within only two years. From 2016 to 2018, the financing volumes totaled around EUR 150, experiencing a sharp increase to EUR 218m in 2019 and EUR 319m in 2020. With 2021, the healthcare VC market in Spain seems to have established a new financing level. Hopefully, Spanish healthcare companies continue to benefit from this trend in the future.

About FCF Life Sciences

FCF Life Sciences advises leading healthcare companies in Europe on financing transactions (equity, debt, and licensing) with regional and international investors. Our team consists of science-driven industry and finance experts with a strong track record in managing financing processes. We thrive to maximize the efficiency in the fundraising process and increase its closing probability.

Learn more about FCF Life Sciences, click here.

We closely track the activity in the financial markets and are passionate about capital markets research. Not every idea or research question make it into the final selection for our publications. However, we generate interesting information on financing trends in Life Sciences sector, which we would like to share in our blog.

To hear from us on the latest insights, please sign up here: